EVE Health Group Limited (EVE) Price & Analysis

Compare

1 Followers

EVE Stock Chart & Stats

AU$0.02

AU$0.00(0.00%)

At close: Dec 30 4:00 PM EST

AU$0.02

AU$0.00(0.00%)

Day’s Range― - ―

52-Week RangeAU$0.02 - AU$0.04

Previous CloseN/A

Volume9.81K

Average Volume (3M)774.07K

Market Cap

AU$5.70M

Enterprise ValueAU$3.93M

Total Cash (Recent Filing)AU$903.42K

Total Debt (Recent Filing)AU$91.28K

Price to Earnings (P/E)―

Beta0.22

Next Earnings

Mar 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding284,876,600

10 Day Avg. Volume491,958

30 Day Avg. Volume774,070

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.22

Price to Sales (P/S)2.49

P/FCF Ratio-2.68

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage / Conservative Capital StructureVery low debt levels give the company durable financial flexibility and lower default risk, important for a small, loss-making operator. Over the next 2–6 months this conservatism supports survival, access to credit and optionality for strategic moves or restructuring.

Improving Free Cash Flow GrowthImprovement in free cash flow growth signals progress in converting operations into spendable cash, a structural strength if sustained. This can reduce reliance on external financing and provide funding for working capital or product initiatives over the medium term.

Stable Equity BaseA relatively stable equity ratio provides a buffer against losses and supports solvency metrics. For a small company with negative earnings, a solid equity base is a durable cushion that improves creditor confidence and preserves operating runway for months ahead.

Bears Say

Declining Revenue TrendMaterial top-line decline undermines scale economics and market positioning. Continued revenue contraction reduces pricing power and makes it harder to cover fixed costs, constraining reinvestment and recovery prospects over a 2–6 month horizon unless growth stabilizes.

Persistent Negative ProfitabilityOngoing negative net margins indicate structural profitability issues and operational inefficiency. Combined with a negative return on equity, this erodes shareholder value and limits internal funding for growth, raising sustainability concerns without meaningful margin turnaround.

Operating Cash Flow WeaknessNegative operating cash flow shows the core business is not generating sufficient cash, forcing dependence on financing or equity injections. Even with FCF improvement, weak operational cash conversion is a durable risk to liquidity and continuity over the medium term.

EVE Health Group Limited News

EVE Health launches erectile dysfunction drug Libbo and integrated men’s digital health platform

An update from EVE Health Group Limited ( ($AU:EVE) ) is now available. EVE Health Group has launched...

11d ago

EVE

EVE Health Moves Into Commercial Phase With First Dyspro Prescriptions and Libbo Manufacturing Milestone

EVE Health Group Limited ( ($AU:EVE) ) has shared an announcement. EVE Health Group has transitioned from development...

21d ago

EVE

EVE Health Group Finalises First Commercial Production of Libbo Erectile Dysfunction Treatment

EVE Health Group Limited ( ($AU:EVE) ) has provided an update. EVE Health Group has completed the first...

22d ago

EVE

EVE Health Director Stuart Gunzburg Increases Stake with On‑Market Share Purchase

EVE Health Group Limited ( ($AU:EVE) ) has issued an update. EVE Health Group Limited has disclosed a...

1M ago

EVE

EVE Health Group Issues New Equity Securities as Part of Employee Incentive Scheme

An update from EVE Health Group Limited ( ($AU:EVE) ) is now available. EVE Health Group Limited announced...

3M ago

EVE

EVE Health Group Issues New Unquoted Securities

EVE Health Group Limited ( ($AU:EVE) ) has shared an update. EVE Health Group Limited has announced the...

3M ago

EVE

EVE Health Group Successfully Passes All Resolutions at General Meeting

EVE Health Group Limited ( ($AU:EVE) ) has provided an announcement. EVE Health Group announced that all resolutions...

3M ago

EVE

EVE Health Group Announces Director’s Shareholding Change

EVE Health Group Limited ( ($AU:EVE) ) has shared an announcement. EVE Health Group Limited has announced a...

3M ago

EVE

EVE Health Group Launches Innovative Products for Women’s and Men’s Health

EVE Health Group Limited ( ($AU:EVE) ) has shared an announcement. EVE Health Group Limited has announced the...

3M ago

EVE

EVE Health Group Enhances Patient Care with New Telehealth Partnership

An update from EVE Health Group Limited ( ($AU:EVE) ) is now available. EVE Health Group Limited has...

3M ago

EVE

EVE FAQ

What was EVE Health Group Limited’s price range in the past 12 months?

EVE Health Group Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.

What is EVE Health Group Limited’s market cap?

EVE Health Group Limited’s market cap is AU$5.70M.

When is EVE Health Group Limited’s upcoming earnings report date?

EVE Health Group Limited’s upcoming earnings report date is Mar 02, 2026 which is in 10 days.

How were EVE Health Group Limited’s earnings last quarter?

EVE Health Group Limited released its earnings results on Aug 29, 2025. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.

Is EVE Health Group Limited overvalued?

According to Wall Street analysts EVE Health Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does EVE Health Group Limited pay dividends?

EVE Health Group Limited does not currently pay dividends.

What is EVE Health Group Limited’s EPS estimate?

EVE Health Group Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EVE Health Group Limited have?

EVE Health Group Limited has 284,876,600 shares outstanding.

What happened to EVE Health Group Limited’s price movement after its last earnings report?

EVE Health Group Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of EVE Health Group Limited?

Currently, no hedge funds are holding shares in AU:EVE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

EVE Health Group Limited Stock Smart Score

Underperform

Blogger Sentiment

Bearish

AU:EVE Sentiment 100%
Sector Average ―

Insider Transactions

Bought Shares

Worth AU$7.2K over
the Last 3 Months

Fundamentals

Return on Equity

-60.84%

Trailing 12-Months

Asset Growth

63.49%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

EVE Health Group Limited

Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.